🇺🇸 FDA
Pipeline program

Peptide A49 associated to melanin, Peptide A52 associated to melanin, Litenimod solution

APHP240512

Phase 2 small_molecule active

Quick answer

Peptide A49 associated to melanin, Peptide A52 associated to melanin, Litenimod solution for glioblastoma is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
glioblastoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials